An upcoming clinical research study is evaluating an investigational long-acting approach designed to help prevent influenza. Join our interest list to receive updates when enrollment opens. A member of our study team may contact you to provide more information and discuss whether you may qualify.
The study will look at the safety of the investigational treatment when given along with a seasonal flu vaccine and whether it affects the body’s immune response to the flu vaccine.
You may be eligible if you:
An upcoming clinical research study is evaluating an investigational treatment designed to help prevent the flu in adults who may […]
An upcoming clinical research study is evaluating an investigational vaccine designed to help prevent illness caused by norovirus in adults […]
An upcoming clinical research study is evaluating an investigational long-acting approach designed to help prevent influenza. Join our interest list […]
Adults 65 and older may qualify for a clinical research study evaluating an investigational seasonal flu vaccine.
This clinical trial will help us learn if receiving another dose of the RSV vaccine is safe and can help […]
Adults 18 years and older may qualify for a study evaluating an investigational oral study medication for elevated lipoprotein(a) [Lp(a)], […]
